We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
-16.97%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$9.02B
AUM Growth
-$307M
Cap. Flow
-$225M
Cap. Flow %
-2.49%
Top 10 Hldgs %
20.75%
Holding
813
New
30
Increased
168
Reduced
3
Closed
20

Top Buys

Rank Stock Value
1
HLT icon
Hilton Worldwide
HLT
+$11.3M
2
PRNB
Principia Biopharma Inc. Common Stock
PRNB
+$2.97M
3
IVZ icon
Invesco
IVZ
+$1.15M
4
MSFT icon
Microsoft
MSFT
+$13.8K
5
AAPL icon
Apple
AAPL
+$12.4K

Top Sells

Rank Stock Value
1
MDCO
Medicines Co
MDCO
+$13.3M
2
WCG
Wellcare Health Plans, Inc.
WCG
+$12.5M
3
INST
Instructure, Inc.
INST
+$9.03M
4
DERM
Dermira, Inc.
DERM
+$8.64M
5
EQH icon
Equitable Holdings
EQH
+$7.36M

Sector Composition

Rank Sector Weight
1 Healthcare 30.92%
2 Technology 19.71%
3 Financials 10.21%
4 Consumer Discretionary 9.38%
5 Communication Services 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MET icon
101
MetLife
MET
$62.4B
$19.7M 0.22%
395,890
+44
+0% +$1.95K
NBIX icon
102
Neurocrine Biosciences
NBIX
$18.2B
$19.6M 0.22%
186,766
– –
PTC icon
103
PTC
PTC
$15.3B
$19.5M 0.22%
266,287
– –
PFE icon
104
Pfizer
PFE
$143B
$19.5M 0.22%
536,298
– –
LH icon
105
Labcorp
LH
$25.2B
$19.3M 0.21%
135,941
+17
+0% +$2.45K
KMB icon
106
Kimberly-Clark
KMB
$37.6B
$19.2M 0.21%
142,431
– –
VAR
107
DELISTED
Varian Medical Systems, Inc.
VAR
$18.9M 0.21%
136,467
+26
+0% +$3.43K
DRNA
108
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$18.9M 0.21%
879,500
– –
DG icon
109
Dollar General
DG
$28.4B
$18.8M 0.21%
123,597
– –
NEE icon
110
NextEra Energy
NEE
$184B
$18.7M 0.21%
315,212
– –
IBM icon
111
IBM
IBM
$213B
$18.6M 0.21%
148,290
+21
+0% +$2.66K
KEYS icon
112
Keysight
KEYS
$50.7B
$18.3M 0.2%
182,805
– –
TIF
113
DELISTED
Tiffany & Co.
TIF
$18.3M 0.2%
140,300
– –
HES
114
DELISTED
Hess
HES
$18.2M 0.2%
278,393
+30
+0% +$1.62K
HOLX
115
DELISTED
Hologic
HOLX
$18.1M 0.2%
355,259
+99
+0% +$4.71K
INTU icon
116
Intuit
INTU
$91.1B
$18M 0.2%
70,213
– –
BAC icon
117
Bank of America
BAC
$429B
$18M 0.2%
521,649
– –
ARNA
118
DELISTED
Arena Pharmaceuticals Inc
ARNA
$17.6M 0.2%
396,800
– –
WBC
119
DELISTED
WABCO HOLDINGS INC.
WBC
$17.6M 0.2%
132,954
– –
BKNG icon
120
Booking.com
BKNG
$156B
$17.6M 0.2%
219,125
– –
ARWR icon
121
Arrowhead Research
ARWR
$12.1B
$17.5M 0.19%
282,508
– –
DFS
122
DELISTED
Discover Financial Services
DFS
$17.2M 0.19%
207,481
– –
CIB icon
123
Grupo Cibest SA
CIB
$21.2B
$17.2M 0.19%
320,904
– –
TAL icon
124
TAL Education Group
TAL
$6.04B
$17.1M 0.19%
362,477
– –
AMD icon
125
Advanced Micro Devices
AMD
$700B
$17.1M 0.19%
380,558
– –
3 4
5
6 7

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q1 2020 Portfolio in Review

As of Q1 2020, Candriam SCA held 813 positions worth $9.02B, down 3.3% from $9.33B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Candriam SCA's Q1 2020 filing shows 30 new, 168 increased, 3 reduced and 20 closed positions. Its largest new stake was Hilton Worldwide: 116,476 shares worth $21.1M. The largest sale was Medicines Co, an estimated $13.3M.

By sector, the portfolio is most concentrated in Healthcare at 31% of assets, up from 31% a quarter earlier, followed by Technology and Financials.

  • Candriam SCA's largest Q1 2020 buy was Hilton Worldwide: 116,476 shares worth $21.1M.
  • Candriam SCA added most to Microsoft in Q1 2020, an estimated $13.8K increase.
  • Candriam SCA's biggest Q1 2020 reduction was Telus, cutting an estimated $1.67M.
  • Candriam SCA fully exited Medicines Co in Q1 2020, selling an estimated $13.3M.
  • Candriam SCA's ten largest holdings make up 21% of its $9.02B portfolio in Q1 2020.
  • Candriam SCA opened 30 new positions and closed 20 in Q1 2020.
  • Candriam SCA's portfolio value fell 3.3% quarter-over-quarter to $9.02B.

Based on Candriam SCA's 13F filing for Q1 2020, filed 26 May 2020.